Clinical Value of Hepatitis B Virus RNA Detection in Patients with Chronic Hepatitis B Infection
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

Hepatitis B virus pregenomic RNA
HBV-pgRNA
Detection
Hepatitis B
Treatment
Clinical value

DOI

10.26689/par.v7i4.4919

Submitted : 2023-06-27
Accepted : 2023-07-12
Published : 2023-07-27

Abstract

Objective: To study the clinical value of hepatitis B virus pregenomic RNA (HBV-pgRNA) detection in the treatment of hepatitis B. Methods: 60 patients with hepatitis B were included in the study. Serum HBV-pgRNA and HBV DNA levels in different phases of infection and during treatment were detected, and serum hepatitis B surface antigen (HbsAg) titer was detected by chemiluminescent immunoassay. DNA was extracted from liver biopsy tissue, and covalently closed circular DNA was detected to predict the therapeutic value in patients. Results: At the initial stage of treatment, the level of HBV-pgRNA in phase I, II, III, and IV showed a gradual decrease. Comparing the levels of HBV-pgRNA before and after treatment, we found that the level of HBV-pgRNA was significantly lower after treatment (P < 0.05). Among the indicators for predicting HBsAg seroconversion, the accuracy of HBV-pgRNA level was 85.0% (51/60). Conclusion: The clinical value of HBV-pgRNA detection in the treatment of hepatitis B is high.

References

Huang Y, Gu W, Zhu H, et al., 2022, Effect of Partial or Complete Deletion of Post-Transcriptional Regulatory Elements on Extranuclear Export of Hepatitis B Virus Pregenomic RNA. Chinese Journal of Practical Diagnosis and Therapy, 36(10): 1017–1021.

Ling X, Wang R, Su M, et al., 2022, The Clinical Significance of Dynamic Monitoring of Serum Hepatitis B Virus Pregenomic RNA in the Treatment of Nucleotide Analogues in Patients with Chronic Hepatitis B. Chinese Journal of Practical Internal Medicine, 42(05): 404–408.

Chen J, Qi W, Hu M, et al., 2022, Correlation Between HBV Pregenome RNA Level and Recurrence Risk After Drug Withdrawal in Patients with Chronic Hepatitis B. Liver, 27(04): 413–417 + 425.

Yan J, Wang C, Liu J, et al., 2022, Predictive Value of Serum Hepatitis B Virus Pregenome RNA Level in Nucleoside (Acid) Analogue-Naïve Chronic Hepatitis B Patients. Practical Hepatology Journal, 25(01): 22–25.

Ma H, Zhao L, Chen W, et al., 2021, Diagnostic Value of Serum Pregenomic RNA Detection in Patients with Hepatitis B Virus Infection with Different Clinical Outcomes. Liver, 26(10): 1150–1153.

Guo Z, Li F, Mo H, 2021, The Relationship Between HBV Pregenomic RNA, Alpha-Fetoprotein Isoform 3 and Hepatitis B X Antibody Levels and HBV-Induced Liver Cancer and the Prognosis of Patients. International Test Journal of Medicine, 42(19): 2390–2393.

Society of Infectious Diseases, Chinese Medical Association, Society of Hepatology, et al., 2019, Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2019 Edition). Chinese Journal of Infectious Diseases, 37(12): 711–736. https://doi.org/10.3760/cma.j.issn.1000-6680.2019.12.003

Ma X, Zheng X, Huang Y, et al., 2022, Effect of Pre-mRNA Splicing Factor 19 Protein on Viral Replication of Hepatitis B Virus Infected Huh7 Cells. Chinese Journal of Practical Diagnosis and Therapy, 36(9): 900–904.

Li X, Li L, Yuan S, et al., 2021, Analysis of the Level of Serum Hepatitis B Virus Pregenome RNA in 70 Cases of Chronic Hepatitis B Patients with Negative Hepatitis B Virus DNA. Chinese Journal of Infectious Diseases, 39(9): 558–561.

Zhang H, Li Y, 2021, Research on the Clinical Significance of Five Items of Hepatitis B and Quantitative Detection of Hepatitis B Virus DNA in Patients with Chronic Hepatitis B. Diet and Health Care, 2021(43): 13–14.

Ren J, 2021, Effect Observation and Detection Rate Analysis of Chemiluminescence Method and Enzyme-Linked Immunoassay in Hepatitis B Virus Serological Test. Diabetes World, 18(3): 141.

Zeng Y, Wang C, He Y, et al., 2022, Clinical Significance of Serum Hepatitis B Virus Pregenomic RNA in Patients with Chronic Hepatitis B Treated with Nucleoside (Acid) Analogues. Journal of Clinical Internal Medicine, 39(11): 751–754.

Lu D, Zheng H, Xi J, et al., 2021, Mechanism of Hepatitis B Virus Pregenomic RNA Selective Translation of Polymerase Protein. Chinese Journal of Hepatology, 29(10): 1035–1040.

Zhang Q, 2022, Application Progress of Serum HBV RNA in Antiviral Therapy. Chongqing Medicine, 51(5): 890–894.

Xu G, Li P, Wu X, 2023, The Value of Hepatitis B Virus Pregenome RNA in Evaluating the Efficacy of Entecavir in the Treatment of Hepatitis B E Antigen Positive Chronic Hepatitis B. Big Doctor, 8(1): 111–113.

Liu Q, Zhang L, Zhang M, et al., 2023, Effect of Pegylated Interferon alfa-2b on Serum Markers HBsAg, HBV-pgNRA, HBV-RNA in Patients with Chronic Hepatitis B. International Journal of Laboratory Medicine, 44(2): 192–195.